JP2016537652A5 - - Google Patents

Download PDF

Info

Publication number
JP2016537652A5
JP2016537652A5 JP2016552704A JP2016552704A JP2016537652A5 JP 2016537652 A5 JP2016537652 A5 JP 2016537652A5 JP 2016552704 A JP2016552704 A JP 2016552704A JP 2016552704 A JP2016552704 A JP 2016552704A JP 2016537652 A5 JP2016537652 A5 JP 2016537652A5
Authority
JP
Japan
Prior art keywords
biomarkers
expression
binding
sample
pancreatic cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016552704A
Other languages
English (en)
Japanese (ja)
Other versions
JP6600637B2 (ja
JP2016537652A (ja
Filing date
Publication date
Priority claimed from GBGB1319878.3A external-priority patent/GB201319878D0/en
Application filed filed Critical
Publication of JP2016537652A publication Critical patent/JP2016537652A/ja
Publication of JP2016537652A5 publication Critical patent/JP2016537652A5/ja
Application granted granted Critical
Publication of JP6600637B2 publication Critical patent/JP6600637B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016552704A 2013-11-11 2014-11-11 膵臓がんを決定するための方法、アレイおよびそれらの使用 Expired - Fee Related JP6600637B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1319878.3 2013-11-11
GBGB1319878.3A GB201319878D0 (en) 2013-11-11 2013-11-11 Method, Array and use thereof
PCT/GB2014/053340 WO2015067969A2 (en) 2013-11-11 2014-11-11 Method, array and use thereof

Publications (3)

Publication Number Publication Date
JP2016537652A JP2016537652A (ja) 2016-12-01
JP2016537652A5 true JP2016537652A5 (cg-RX-API-DMAC7.html) 2017-12-07
JP6600637B2 JP6600637B2 (ja) 2019-10-30

Family

ID=49818441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016552704A Expired - Fee Related JP6600637B2 (ja) 2013-11-11 2014-11-11 膵臓がんを決定するための方法、アレイおよびそれらの使用

Country Status (12)

Country Link
US (3) US20160252513A1 (cg-RX-API-DMAC7.html)
EP (1) EP3069143B1 (cg-RX-API-DMAC7.html)
JP (1) JP6600637B2 (cg-RX-API-DMAC7.html)
KR (1) KR102240473B1 (cg-RX-API-DMAC7.html)
CN (1) CN105917230B (cg-RX-API-DMAC7.html)
AU (1) AU2014345484B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016010510A2 (cg-RX-API-DMAC7.html)
CA (1) CA2930211A1 (cg-RX-API-DMAC7.html)
ES (1) ES2704888T3 (cg-RX-API-DMAC7.html)
GB (1) GB201319878D0 (cg-RX-API-DMAC7.html)
MX (1) MX2016006125A (cg-RX-API-DMAC7.html)
WO (1) WO2015067969A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008231575A1 (en) 2007-03-27 2008-10-02 Immunovia Ab Protein signature/markers for the detection of adenocarcinoma
GB201014837D0 (en) 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
CN105021825B (zh) * 2015-07-09 2016-08-17 陈勇 一种检测胰腺癌相关多肽dap44的elisa试剂盒
GB201516801D0 (en) 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
GB201609950D0 (en) * 2016-06-07 2016-07-20 Immunovia Ab Biomarkers signatures and uses thereof
GB201609951D0 (en) * 2016-06-07 2016-07-20 Immunovia Ab Biomarkers signatures and uses thereof
CN110402393A (zh) * 2016-11-24 2019-11-01 休伯特保健公司 疾病诊断的组合物
GB201701572D0 (en) * 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
KR102536314B1 (ko) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 질환의 진단용 조성물
US11487739B2 (en) * 2019-02-19 2022-11-01 Nasdaq, Inc. System and methods for data model detection and surveillance
CA3138991A1 (en) * 2019-05-02 2020-11-05 Ligandal, Inc. Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents
EP3974541A4 (en) * 2019-05-21 2023-10-11 Acurasysbio Co., Ltd. COMPOSITION FOR CANCER DIAGNOSIS
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
KR102226826B1 (ko) * 2020-08-06 2021-03-11 주식회사 휴벳바이오 버피 코트 시료에 사용하기 위한 췌장암 진단용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3169789D1 (en) 1980-05-02 1985-05-15 Edward P Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US6727066B2 (en) * 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
CN1659287A (zh) * 2002-04-05 2005-08-24 美国政府健康及人类服务部 诊断肝癌转移或发病可能性及鉴定治疗靶点的方法
JP4679149B2 (ja) * 2002-09-30 2011-04-27 オンコセラピー・サイエンス株式会社 ヒト膵癌に関連する遺伝子およびポリペプチド
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
US7217807B2 (en) * 2002-11-26 2007-05-15 Rosetta Genomics Ltd Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
CA2531118C (en) * 2003-07-01 2013-01-08 Immunomedics, Inc. Multivalent carriers of bi-specific antibodies
KR101282396B1 (ko) * 2004-05-28 2013-07-04 어젠시스 인코포레이티드 Psca 단백질에 결합하는 암 진단용 항체
US8383357B2 (en) * 2005-03-16 2013-02-26 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
EP1910557A2 (en) * 2005-04-07 2008-04-16 Chiron Corporation Cancer-related genes
JP2007051880A (ja) * 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
DK1974058T3 (da) * 2006-01-11 2014-09-01 Genomic Health Inc Genekspressionsmarkører til prognosticering af kolorektal cancer
AU2008231575A1 (en) * 2007-03-27 2008-10-02 Immunovia Ab Protein signature/markers for the detection of adenocarcinoma
CA2691980C (en) * 2007-06-29 2022-05-10 Correlogic Systems, Inc. Predictive markers for ovarian cancer
JP2011516826A (ja) * 2008-03-07 2011-05-26 オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド 間葉系様腫瘍細胞またはこの形成を阻害する作用剤の同定のための方法
GB0815846D0 (en) * 2008-09-01 2008-10-08 Immunovia Ab diagnosis, prognosis and imaging of disease
JP2012520469A (ja) * 2009-03-12 2012-09-06 キャンサー・プリヴェンション・アンド・キュア,リミテッド 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療の方法並びにそのキット
EP2483690A1 (de) * 2009-09-29 2012-08-08 Protagen AG Markersequenzen für pankreaskrebserkrankungen, pankreaskarzinom und deren verwendung
MY185582A (en) * 2010-01-07 2021-05-24 Malaysian Palm Oil Board Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease
CN102279264A (zh) * 2010-06-09 2011-12-14 李彬 48种恶性肿瘤标志物抗体芯片的制备方法
CN106011233A (zh) * 2010-08-13 2016-10-12 莫尔豪斯医学院 中风的生物标记
GB201103726D0 (en) * 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
WO2012139628A1 (en) * 2011-04-11 2012-10-18 Lykera Biomed Sa Coding polypurine hairpins for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2016537652A5 (cg-RX-API-DMAC7.html)
Bader et al. MS-based proteomics of body fluids: the end of the beginning
Zhao et al. Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application
Kupcova Skalnikova et al. Advances in proteomic techniques for cytokine analysis: focus on melanoma research
CN112119166B (zh) 无细胞dna染色质免疫沉淀的诊断应用
Shi et al. A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum
US12205677B2 (en) System and method for analysis of biological data
US20200182874A1 (en) Plasma autoantibody biomarkers for basal like breast cancer
CN108034724B (zh) 用于预测结直肠癌预后及死亡风险的环状rna分子标记物及其应用
JP2013541697A5 (cg-RX-API-DMAC7.html)
JP2010522875A5 (cg-RX-API-DMAC7.html)
JP2015505370A5 (cg-RX-API-DMAC7.html)
Zhang et al. Quantitative proteome‐based systematic identification of SIRT7 substrates
Nie et al. Deep-dive targeted quantification for ultrasensitive analysis of proteins in nondepleted human blood plasma/serum and tissues
JP2016519767A5 (cg-RX-API-DMAC7.html)
Zeng et al. Highly sensitive and specific graphene oxide-based FRET aptasensor for quantitative detection of human soluble growth stimulating gene protein 2
CN104812914B (zh) 诊断受试者中的肝癌的方法及诊断肝癌的试剂盒
JP2017508983A (ja) サーマルシフトアッセイを使用して薬物反応の減少の指標となるバイオマーカーを識別するための方法
Nazari et al. Aptamer-based sandwich assay for measurement of thymidine kinase 1 in serum of cancerous patients
CN106011142A (zh) 一种特异识别psa蛋白的寡核苷酸配基p7-26的序列和应用
KR20230074025A (ko) 세포 노화 바이오 마커 ac008012.1, cldn11, hmgn2, chaf1b 또는 klhl13, 및 이를 이용한 세놀리틱 약물을 스크리닝 하는 방법
US20230133776A1 (en) Methods for diagnosing cancer
CN113791218B (zh) 一种用于评估超米兰标准肝癌患者肝移植后肿瘤复发风险的试剂盒
Muthelo et al. Magnetic Bead Based Proximity Extension Assay for Sensitive Protein and Extracellular Vesicles Detection
CN113740535B (zh) 检测肝肿瘤组织豪猪音配体的方法